Literature DB >> 26929196

Global emergence of enterovirus D68: a systematic review.

Charlotte Carina Holm-Hansen1, Sofie Elisabeth Midgley1, Thea Kølsen Fischer2.   

Abstract

Since its discovery in California in 1962, reports of enterovirus D68 have been infrequent. Before 2014, infections were confirmed in only 699 people worldwide. In August, 2014, two paediatric hospitals in the USA reported increases in the number of patients with severe respiratory illness, with an over-representation in children with asthma. Shortly after, the authorities recognised a nationwide outbreak, which then spread to Canada, Europe, and Asia. In 2014, more than 2000 cases of enterovirus D68 were reported in 20 countries. Concurrently, clusters of children with acute flaccid paralysis of unknown cause were reported in several US states and in Europe. Enterovirus D68 infection was confirmed in some of the paralysed children, but not all. Complications in patients who were severely neurologically affected resemble those caused by poliomyelitis. In this paper we systematically review reports on enterovirus D68 to estimate its global epidemiology and its ability to cause respiratory infections and neurological damage in children. We extracted data from 70 papers to report on prevalence, symptoms, hospitalisation and mortality, and complications of enterovirus D68, both before and during the large outbreak of 2014. The magnitude and severity of the enterovirus D68 outbreak underscores a need for improved diagnostic work-up of paediatric respiratory illness, not only to prevent unnecessary use of antibiotics, but also to ensure better surveillance of diseases. Existing surveillance systems should be assessed in terms of capacity and ability to detect and report any upsurge of respiratory viruses such as enterovirus D68 in a timely manner, and focus should be paid to development of preventive measures against these emerging enteroviruses that have potential for severe disease.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26929196     DOI: 10.1016/S1473-3099(15)00543-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  103 in total

1.  Development of broad-spectrum enterovirus antivirals based on quinoline scaffold.

Authors:  Rami Musharrafieh; Naoya Kitamura; Yanmei Hu; Jun Wang
Journal:  Bioorg Chem       Date:  2020-06-01       Impact factor: 5.275

Review 2.  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Authors:  Anna Egorova; Sean Ekins; Michaela Schmidtke; Vadim Makarov
Journal:  Eur J Med Chem       Date:  2019-06-11       Impact factor: 6.514

Review 3.  Acute Flaccid Paralysis and Enteroviral Infections.

Authors:  Ari Bitnun; E Ann Yeh
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

4.  Rational Control of Poliovirus RNA-Dependent RNA Polymerase Fidelity by Modulating Motif-D Loop Conformational Dynamics.

Authors:  Jingjing Shi; Jacob M Perryman; Xiaorong Yang; Xinran Liu; Derek M Musser; Alyson K Boehr; Ibrahim M Moustafa; Jamie J Arnold; Craig E Cameron; David D Boehr
Journal:  Biochemistry       Date:  2019-08-26       Impact factor: 3.162

5.  Molecular basis for the acid-initiated uncoating of human enterovirus D68.

Authors:  Yue Liu; Ju Sheng; Arno L W van Vliet; Geeta Buda; Frank J M van Kuppeveld; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

6.  Not your usual tRNA synthetase: hWARS serves as an enterovirus entry factor.

Authors:  Stanley Perlman; Tom Gallagher
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 14.808

7.  Biennial Upsurge and Molecular Epidemiology of Enterovirus D68 Infection in New York, USA, 2014 to 2018.

Authors:  Victoria L Gilrane; Jian Zhuge; Weihua Huang; Sheila M Nolan; Abhay Dhand; Changhong Yin; Christian Salib; Faariah Shakil; Helen Engel; John T Fallon; Guiqing Wang
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

8.  Validating Enterovirus D68-2Apro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2Apro Inhibitor.

Authors:  Rami Musharrafieh; Chunlong Ma; Jiantao Zhang; Yanmei Hu; Jessica M Diesing; Michael T Marty; Jun Wang
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

9.  Enterovirus D68 infection induces IL-17-dependent neutrophilic airway inflammation and hyperresponsiveness.

Authors:  Charu Rajput; Mingyuan Han; J Kelley Bentley; Jing Lei; Tomoko Ishikawa; Qian Wu; Joanna L Hinde; Amy P Callear; Terri L Stillwell; William T Jackson; Emily T Martin; Marc B Hershenson
Journal:  JCI Insight       Date:  2018-08-23

10.  Acute Flaccid Myelitis in German Children in 2016-the Return of Polio?

Authors:  Johannes Hübner; Bernd Kruse; Hans-Jürgen Christen; Jürgen Weidenmann; Viktoria Weiner; Jan-Christoph Schöne-Bake; Anna Eichinger; Sabine Diedrich; Wolfgang Müller-Felber
Journal:  Dtsch Arztebl Int       Date:  2017-08-21       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.